Table 3. Treatment comparisons between the US and the UK.
| US | UK | US-UK Difference (95% CI) | p-value | |||
|---|---|---|---|---|---|---|
|
| ||||||
| Treatment | Total n | n(%) | Total n | n(%) | ||
|
| ||||||
| Hypertonic saline; n(%) | ||||||
| <18 years | 13412 | 5489 (40.9) | 39073 | 327 (8.4) | 32.6 (31.4, 33.8) | <0.001 |
| ≥18 years | 10803 | 5594 (51.8) | 870 | 571 (14.8) | 37.0 (35.6, 38.5) | <0.001 |
|
| ||||||
| Any nebulised antibiotic, n(%) | ||||||
| <18 years | 13412 | 6000 (44.7) | 3907 | 1674 (42.9) | 1.9 (0.1, 3.7) | 0.036 |
| ≥18 years | 10803 | 7079 (65.5) | 3870 | 2396 (61.9) | 3.6 (1.8, 5.4) | <0.001 |
|
| ||||||
| rhDNase; n(%) | ||||||
| <18 years | 13412 | 10360 (77.2) | 3907 | 1382 (35.4) | 41.9 (40.2, 43.5) | <0.001 |
| ≥18 years | 10803 | 8126 (75.2) | 3870 | 2009 (51.9) | 23.3 (21.5, 25.1) | <0.001 |
|
| ||||||
| Macrolides, n(%) | ||||||
| <18 years | 13412 | 4505 (33.6) | 3907 | 942 (24.1) | 9.5 (7.9, 11.0) | <0.001 |
| ≥18 years | 10803 | 7061 (65.4) | 3870 | 2373 (61.3) | 4.0 (2.3, 5.8) | <0.001 |